Junichiro Yuda

15PUBLICATIONS
86CO-AUTHORS
Immunogenetics (incl. genetic immunology)Haematological tumoursHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 07, 2026
Incidence, Clinical Characteristics, Management, and Outcomes of Hematologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors: A Single-Center Japanese Retrospective Cohort Study.

|Jun 29, 2026
Molecular Relapse After a Second Treatment-Free Remission Attempt Following Asciminib in Chronic Myeloid Leukemia: A Case Report.

|May 23, 2026
SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies.

|Dec 27, 2025
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO.

Gurdeep Parmar, Marcelo Capra, Fernanda Seguro

|May 09, 2025
Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MM.

Shinsuke Iida, Kazutaka Sunami, Shigeki Ito

|Oct 21, 2024
Treatment selection and influencing factors for chronic lymphocytic leukemia: a physician survey in Japan.

Junichiro Yuda, Chaochen Wang, Tomoko Terasawa

Pageof 3

Frequent Collaborators

2 joint publications

Genichiro Ishii

2 joint publications

Kazutaka Sunami

2 joint publications

Takao Fujisawa

1 joint publications

Toshihiro Miyamoto